Catherine Isted has joined cell-based therapeutics company ReNeuron as chief financial officer.
Isted was previously head of corporate development and investor relations in the finance leadership team at Oxford Biomedica, and is a former partner in the healthcare equities team at Peel Hunt. She has also held research analyst and equity sales positions in the healthcare teams at Morgan Stanley, ABN AMRO and Nomura.
Iain Ross, ReNeuron chair, commented: “Catherine has an excellent knowledge of the healthcare sector and is highly skilled in equity capital markets, M&A and strategic business development. She will be a fantastic addition to the ReNeuron board and I am thoroughly looking forward to working alongside her.”